Table 2.

Global and country-specific Patient Activation Measure-13 (PAM) results

Levels	Level 1	Level 2	Level 3	Level 4
Total (%)
Overall n	116 (25.44)	78 (17.11)	217 (47.59)	46 (10.09)
Female n	51 (24.76)	31 (15.05)	103 (50.00)	22 (10.68)
Male n	65 (26.00)	47 (18.80)	114 (45.60)	24 (9.60)
Australia (%)
Overall n	11 (26.83)	5 (12.20)	21 (51.22)	4 (9.76)
Female n	4 (19.05)	1 (4.76)	12 (57.14)	4 (19.05)
Male n	7 (35.00)	4 (20.00)	9 (45.00)	0
Canada (%)
Overall n	5 (11.11)	9 (20.00)	23 (51.11)	8 (17.78)
Female n	2 (6.90)	8 (27.59)	14 (48.28)	5 (17.24)
Male n	3 (18.75)	1 (6.25)	9 (56.25)	3 (18.75)
Germany (%)
Overall n	12 (29.27)	4 (9.76)	19 (46.34)	6 (14.63)
Female n	5 (26.32)	0	11 (57.89)	3 (15.79)
Male n	7 (31.82)	4 (18.18)	8 (36.36)	3 (13.64)
Spain %
Overall n	14 (35.00)	9 (22.50)	11 (27.50)	6 (15.00)
Female n	5 (35.71)	4 (28.57)	2 (14.29)	3 (21.43)
Male n	9 (34.62)	5 (19.23)	9 (34.62)	3 (11.54)
France (%)
Overall n	15 (37.50)	8 (20.00)	15 (37.50)	2 (5.00)
Female n	4 (26.67)	2 (13.33)	8 (53.33)	1 (6.67)
Male n	11 (44.00)	6 (24.00)	7 (28.00)	1 (4.00)
Italy (%)
Overall n	14 (36.84)	10 (26.32)	12 (31.58)	2 (5.26)
Female n	9 (50.00)	3 (16.67)	6 (33.33)	0
Male n	5 (25.00)	7 (35.00)	6 (30.00)	2 (10.00)
Japan (%)
Overall n	31 (70.45)	7 (15.91)	6 (13.64)	0
Female n	20 (68.97)	5 (17.24)	4 (13.79)	0
Male n	11 (73.33)	2 (13.33)	2 (13.33)	0
Taiwan (%)
Overall n	1 (1.67)	9 (15.00)	45 (75.00)	5 (8.33)
Female n	0	4 (13.79)	24 (82.76)	1 (3.45)
Male n	1 (3.23)	5 (16.13)	21 (67.74)	4 (12.90)
United Kingdom (%)
Overall n	9 (23.08)	4 (10.26)	22 (56.41)	4 (10.26)
Female n	2 (15.38)	1 (7.69)	8 (61.54)	2 (15.38)
Male n	7 (26.92)	3 (11.54)	14 (53.85)	2 (7.69)
USA (%)
Overall n	4 (5.80)	13 (18.84)	43 (62.32)	9 (13.04)
Female n	0	3 (15.00)	14 (70.00)	3 (15.00)
Male n	4 (8.16)	10 (20.41)	29 (59.18)	6 (12.24)

Level 1, strongly disagree; level 4, strongly agree